Reports Q2 revenue $662.4M, consensus $689.08M. “Fortrea continues to make progress with customers and our business, which is not reflected in the headline numbers,” said Tom Pike, chairman and CEO of Fortrea. “We won some important opportunities this quarter. We have increased our focus as an innovative, global pure-play clinical services organization. We have now exited 60 percent of our Transition Services Agreement and are making good progress on the most difficult part, the IT systems, and managing the related one-time costs. We have reduced our debt. We have our margin improvement actions in focus. We are transforming. I’m confident we’re headed in the right direction to deliver value for all our stakeholders, delivering solutions that bring new treatments to patients faster.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
- Fortrea Holdings Inc. (FTRE) Q2 Earnings Cheat Sheet
- Fortrea Holdings downgraded to In Line from Outperform at Evercore ISI
- Labcorp price target raised to $260 from $240 at BofA
- Fortrea Holdings reinstated with an Equal Weight at Barclays
- Fortrea Holdings removed from ‘Tactical Outperform’ list at Evercore ISI